Wiley Bros. Aintree Capital, LLC Johnson & Johnson Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 425,094 shares of JNJ stock, worth $69.6 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
425,094
Previous 252,384
68.43%
Holding current value
$69.6 Million
Previous $40.9 Million
50.31%
% of portfolio
0.76%
Previous 0.81%
Shares
27 transactions
Others Institutions Holding JNJ
# of Institutions
4,535Shares Held
1.73BCall Options Held
16.8MPut Options Held
13.9M-
Vanguard Group Inc Valley Forge, PA233MShares$38.1 Billion0.6% of portfolio
-
Black Rock Inc. New York, NY198MShares$32.4 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$22 Billion0.79% of portfolio
-
Geode Capital Management, LLC Boston, MA57.7MShares$9.44 Billion0.66% of portfolio
-
Morgan Stanley New York, NY43.9MShares$7.18 Billion0.46% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $428B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...